GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Price-to-Free-Cash-Flow

ACME Laboratories (DHA:ACMELAB) Price-to-Free-Cash-Flow : N/A (As of Sep. 21, 2024)


View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Price-to-Free-Cash-Flow?

As of today (2024-09-21), ACME Laboratories's share price is BDT89.20. ACME Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was BDT-17.97. Hence, ACME Laboratories's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for ACME Laboratories's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 8 years, ACME Laboratories's highest Price-to-Free-Cash-Flow Ratio was 118.23. The lowest was 45.46. And the median was 49.34.

DHA:ACMELAB's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 21.66
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

ACME Laboratories's Free Cash Flow per Share for the three months ended in Mar. 2024 was BDT0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was BDT-17.97.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -61.00% per year.

During the past 8 years, ACME Laboratories's highest 3-Year average Free Cash Flow per Share Growth Rate was 30.90% per year. The lowest was -61.00% per year. And the median was -20.50% per year.


ACME Laboratories Price-to-Free-Cash-Flow Historical Data

The historical data trend for ACME Laboratories's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Price-to-Free-Cash-Flow Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - 17.04 - -

ACME Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ACME Laboratories's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACME Laboratories's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ACME Laboratories's Price-to-Free-Cash-Flow falls into.



ACME Laboratories Price-to-Free-Cash-Flow Calculation

ACME Laboratories's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=89.20/-17.973
=N/A

ACME Laboratories's Share Price of today is BDT89.20.
ACME Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-17.97.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

ACME Laboratories  (DHA:ACMELAB) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


ACME Laboratories Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


ACME Laboratories Business Description

Traded in Other Exchanges
N/A
Address
1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories Headlines

No Headlines